Medicines Co. (MDCO) Posts Surprise Q1 Profit

Medicines Co. (NASDAQ: MDCO) reported Q1 adjusted EPS of $0.08, $0.92 better than the analyst estimate of ($0.84). Revenue for the quarter came in at $126.5 million versus the consensus estimate of $138.78 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79